Wednesday, May 30, 2018

Vasopressin might be a marker, treatment for autism, studies suggest


Boosting vasopressin levels in unsocial rhesus macaques improved social function, according to research published in Scientific Reports, and a study reported in Science Translational Medicine found most monkeys studied were correctly classified as highly social or unsocial based only on vasopressin levels in cerebrospinal fluid. The findings support the hypothesis that vasopressin plays a role in autism spectrum disorder, and enrollment is underway in a clinical trial to study whether vasopressin can ease ASD symptoms.   Spectrum News (5/29) 

No comments: